✦ LIBER ✦

MTA (LY231514): a phase II trial in patients (PTS) with non-small cell lung cancer (NSCLC) who relapsed after previous platinum or non-platinum chemotherapy

✍ Scribed by von Pawel, J.; Manegold, C.; Mattson, K.; Postmus, P.E.; Smit, E.F.; Clarke, S.; Saarinen, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of mta (LY231514) in pati

✍ P. Postmus; K. Mattson; von Pawel; C. Manegold; E. Smit; M. Millward; S. Clarke; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Phase II trial of the multi-targeted ant

✍ Rusthoven, J.; Eisenhauer, E.; Butts, C.; Gregg, R.; Dancey, J.; Fisher, B.; Igl 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 261 KB

1070 Phase II trial with docetaxel in pa

✍ Latreille, J.; Laberge, F.; Viallet, J.; Maksymiuk, A.; Shepherd, F.; Gelmon, K. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 163 KB

210 Phase III study with gemcitabine — V

✍ Biesma, B.; Postmus, P.E. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Phase II trial of MTA (AlimtaTM) and cis

✍ Shepherd, F.A; Arnold, A; Neville, A; Dancey, J; Rusthoven, J; Fisher, B; Eisenh 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Gemcitabine in Patients with Non–Small-C

✍ Primo N. Lara Jr; Paul H. Gumerlock; Philip C. Mack; Derick H.M. Lau; Regina Gan 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 327 KB